Policy / Pricing UK partners with Eli Lilly on obesity plan PharmaphorumThe UK has teamed up with Eli Lilly on initiatives, backed with 85 million in funding, to expand access to treatment for obesity.Metabolic & GLP-1Read full story pharminent June 29, 2026 (Last updated: June 29, 2026) Pharmaphorum The UK has teamed up with Eli Lilly on initiatives, backed with 85 million in funding, to expand access to treatment for obesity. Metabolic & GLP-1 Read full story Post navigation Previous: Zymeworks cuts deal to buy Theravance for $929m in cashNext: Viridian’s Lumvoa Wins FDA Approval, Taking Direct Aim at Amgen’s Tepezza in Thyroid Eye Disease Related Stories Policy / Pricing Prior Authorization Metrics Provide New Insights into Insurer Practices, but Gaps Remain pharminent August 13, 2026 Policy / Pricing Trump signs order that nearly halves childhood immunisation coverage pharminent August 11, 2026 Policy / Pricing US generic tariff reprieve on the rocks as Trump proposes 100% rate in 2028 pharminent July 22, 2026
